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Résumé en
anglais
In the past, plasma membrane-derived microparticles were considered "cellular
dust." According to the literature, circulating levels of microparticles are increased
in several cardiovascular diseases associated with inflammation, suggesting that
microparticles are linked to deleterious effects such as endothelial dysfunction or
thrombosis. However, very recent studies have shown that under several conditions
microparticles can transfer biological messages between cells. Indeed,
microparticles act as vectors of key information to maintain cell homeostasis or to
favor cell repair and induce angiogenesis. For instance, microparticles of platelet
origin are able to repair myocardial injury after myocardial infarction. Also, we have
shown that engineered microparticles generated from human activated/apoptotic T
cells promote angiogenesis through the up-regulation of adhesion proteins and pro-
angiogenic factors in human endothelial cells. Interestingly, the effects induced by
these microparticles on the formation of capillary-like structures, expression of
adhesion molecules, and pro-angiogenic factors are reversed after silencing of the
Sonic Hedgehog (Shh) morphogen pathway. In addition, the same type of
microparticles is able to induce neo-vascularization in an ischemic hindlimb model.
These effects are, at least in part, mediated by Shh and nitric oxide production.
Taking into consideration these results and the most recent data concerning the
ability of microparticles to transmit genetic information between cells through
mRNA transfer, it is plausible that plasma membrane-derived microparticles could
serve as tools with veritable therapeutic potential.
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